SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : QLT PhotoTherapeutics (QLTI)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Scripts who wrote (1095)10/17/2000 9:12:53 PM
From: Ian@SI  Read Replies (1) of 1321
 
Ed,

Another potential revenue increasing decision is still pending: Whether or not to initiate direct marketing to the consumers.

There's about 3 years of patients who've been told there's no treatment available, yet still have some vision that's worth preserving. If they're somehow still unaware of Visudyne, there's huge upside by attracting even a small percentage of them into retinal specialists' offices.

Others may not be aware they have the symptoms of AMD; and just don't go to their doctor on a timely basis. A direct marketing program; or consumer awareness program, would be a lifesaver for these people.

Regards,
Ian.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News